Ninepoint Partners LP
-4.07%
3-Monats-Rendite
$25.780
0.000 (0.00%)Zum Schluss
Credit Enhanced Corts Trust For Aon Capital A is a United States-based company. The Company provides financial services.
Currently, KTN is not a strong buy. The stock's current price is $25.78, which is 34.1% of its 52-week range, indicating it is closer to the lower end of its yearly performance. The RSI is at 56.398, suggesting it is neither overbought nor oversold, but the lack of significant momentum is concerning. The 1-year change is -2.75%, indicating a decline over the past year, which raises caution for long-term investors. The main risk is its low trading volume of 683 compared to the average 20-day volume of 2641, indicating potential liquidity issues.

Kootenay Silver Initiates PEA for La Cigarra, Expected Completion in Q2 2026

Kootenay Silver Engages SFLLC for Investor Relations Services

Metals and Mining Virtual Investor Conference: Presentations Now Available for Online Viewing

Kootenay Silver Inc. to Present at the Metals & Mining Virtual Investor Conference May 6th 2025

Metals & Mining Virtual Investor Conference Agenda Announced for May 6-8th
Credit Enhanced Corts Trust For Aon Capital A is a United States-based company. The Company provides financial services. It operates in the Financials sector.
Currently, KTN is not a strong buy. The stock's current price is $25.78, which is 34.1% of its 52-week range, indicating it is closer to the lower end of its yearly performance. The RSI is at 56.398, suggesting it is neither overbought nor oversold, but the lack of significant momentum is concerning. The 1-year change is -2.75%, indicating a decline over the past year, which raises caution for long-term investors. The main risk is its low trading volume of 683 compared to the average 20-day volume of 2641, indicating potential liquidity issues.
Noch keine Beiträge
Registriere dich oder melde dich an, um mitzudiskutierenDiese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.